Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL CBD HEMP OIL INDUSTRY
2.1 Summary about CBD Hemp Oil Industry
2.2 CBD Hemp Oil Market Trends
2.2.1 CBD Hemp Oil Production & Consumption Trends
2.2.2 CBD Hemp Oil Demand Structure Trends
2.3 CBD Hemp Oil Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Food Grade
4.2.2 Pharmaceutical Grade
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Anxiety
4.3.2 Fibromyalgia (FM)
4.3.3 Diabetes
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Food Grade
5.2.2 Pharmaceutical Grade
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Anxiety
5.3.2 Fibromyalgia (FM)
5.3.3 Diabetes
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Food Grade
6.2.2 Pharmaceutical Grade
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Anxiety
6.3.2 Fibromyalgia (FM)
6.3.3 Diabetes
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Food Grade
7.2.2 Pharmaceutical Grade
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Anxiety
7.3.2 Fibromyalgia (FM)
7.3.3 Diabetes
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Food Grade
8.2.2 Pharmaceutical Grade
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Anxiety
8.3.2 Fibromyalgia (FM)
8.3.3 Diabetes
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Food Grade
9.2.2 Pharmaceutical Grade
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Anxiety
9.3.2 Fibromyalgia (FM)
9.3.3 Diabetes
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 ENDOCA
10.1.2 CBD American Shaman
10.1.3 Gaia Botanicals
10.1.4 Isodiol
10.1.5 Medical Marijuana
10.1.6 Aurora Cannabis (AC)
10.1.7 Cannoid
10.1.8 Canopy Growth Corporation
10.1.9 CV Sciences
10.1.10 IRIE CBD
10.1.11 Elixinol
10.1.12 NuLeaf Naturals
10.1.13 PharmaHemp
10.1.14 Folium Biosciences
10.2 CBD Hemp Oil Sales Date of Major Players (2017-2020e)
10.2.1 ENDOCA
10.2.2 CBD American Shaman
10.2.3 Gaia Botanicals
10.2.4 Isodiol
10.2.5 Medical Marijuana
10.2.6 Aurora Cannabis (AC)
10.2.7 Cannoid
10.2.8 Canopy Growth Corporation
10.2.9 CV Sciences
10.2.10 IRIE CBD
10.2.11 Elixinol
10.2.12 NuLeaf Naturals
10.2.13 PharmaHemp
10.2.14 Folium Biosciences
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
1.Table CBD Hemp Oil Product Type Overview
2.Table CBD Hemp Oil Product Type Market Share List
3.Table CBD Hemp Oil Product Type of Major Players
4.Table Brief Introduction of ENDOCA
5.Table Brief Introduction of CBD American Shaman
6.Table Brief Introduction of Gaia Botanicals
7.Table Brief Introduction of Isodiol
8.Table Brief Introduction of Medical Marijuana
9.Table Brief Introduction of Aurora Cannabis (AC)
10.Table Brief Introduction of Cannoid
11.Table Brief Introduction of Canopy Growth Corporation
12.Table Brief Introduction of CV Sciences
13.Table Brief Introduction of IRIE CBD
14.Table Brief Introduction of Elixinol
15.Table Brief Introduction of NuLeaf Naturals
16.Table Brief Introduction of PharmaHemp
17.Table Brief Introduction of Folium Biosciences
18.Table Products & Services of ENDOCA
19.Table Products & Services of CBD American Shaman
20.Table Products & Services of Gaia Botanicals
21.Table Products & Services of Isodiol
22.Table Products & Services of Medical Marijuana
23.Table Products & Services of Aurora Cannabis (AC)
24.Table Products & Services of Cannoid
25.Table Products & Services of Canopy Growth Corporation
26.Table Products & Services of CV Sciences
27.Table Products & Services of IRIE CBD
28.Table Products & Services of Elixinol
29.Table Products & Services of NuLeaf Naturals
30.Table Products & Services of PharmaHemp
31.Table Products & Services of Folium Biosciences
32.Table Market Distribution of Major Players
33.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
34.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
35.Table Global CBD Hemp Oil Market Forecast (Million USD) by Region 2021f-2026f
36.Table Global CBD Hemp Oil Market Forecast (Million USD) Share by Region 2021f-2026f
37.Table Global CBD Hemp Oil Market Forecast (Million USD) by Demand 2021f-2026f
38.Table Global CBD Hemp Oil Market Forecast (Million USD) Share by Demand 2021f-2026f